欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, esafoxolaner, praziquantel - eprinomectin, combinations, , avermectins, antiparasitic products, insecticides and repellents - cats - for cats with, or at risk from mixed infections by cestodes, nematodes and ectoparasites. the veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - chicken - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - modified live bovine viral diarrhoea virus type 1, non-cytopathic parent strain ke-9 and modified live bovine viral diarrhoea virus type 2, non-cytopathic parent strain ny-93 - immunologicals for bovidae, live viral vaccines - for active immunisation of cattle from 3 months of age to reduce hyperthermia and to minimise the reduction of leukocyte count caused by bovine viral diarrhoea virus (bvdv-1 and bvdv-2), and to reduce virus shedding and viraemia caused by bvdv-2.for active immunisation of cattle against bvdv-1 and bvdv-2, to prevent the birth of persistently infected calves caused by transplacental infection.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - imepitoin - other antiepileptics, antiepileptics - dogs - for the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - porcine circovirus type 2 orf2 protein - immunologicals for suidae - pigs - for active immunisation of pigs with no pcv2 maternally derived antibodies from the age of 2 weeks against porcine circovirus type 2 (pcv2),

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - porcine parvovirus, strain 27a, viral protein 2 - immunologicals for suidae - pigs - for active immunisation of gilts and sows from the age of 5 months to protect progeny against transplacental infection caused by porcine parvovirus.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ciclesonide - respiratory system, other drugs for obstructive airway diseases, inhalants - horses - for the alleviation of clinical signs of severe equine asthma (formerly known as recurrent airway obstruction – (rao), summer pasture associated recurrent airway obstruction – (spa-rao)).

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxetine - diabetic neuropathies - psychoanaleptics, - treatment of diabetic peripheral neuropathic pain in adults.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs.onsets of immunity isone week after primary vaccination course.the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

欧盟 - 英文 - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - immunologicals for felidae, - cats - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs.onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.